Cargando…

Efficacy and Safety of Iguratimod Supplement to the Standard Immunosuppressive Regimen in Highly Mismatched Renal Transplant Recipients: A Pilot Study

Iguratimod (IGU) can mitigate the symptoms of rheumatoid arthritis through its anti-inflammatory effects. The objective of this study was to investigate the clinical efficacy and safety of IGU in highly HLA-mismatched renal transplant recipients, in combination with standard immunosuppressive regime...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tao, Jun, Sun, Li, Wang, Zijie, Chen, Hao, Han, Zhijian, Zhang, Hengcheng, Yang, Haiwei, Huang, Zhengkai, Fei, Shuang, Ju, Xiaobin, Tan, Ruoyun, Gu, Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650225/ https://www.ncbi.nlm.nih.gov/pubmed/34887851 http://dx.doi.org/10.3389/fimmu.2021.738392

Ejemplares similares

Iguratimod Attenuates Macrophage Polarization and Antibody-Mediated Rejection After Renal Transplant by Regulating KLF4
por: Hang, Zhou, et al.
Publicado: (2022)

Role of B and T Lymphocyte Attenuator in Renal Transplant Recipients with Biopsy-Proven Acute Rejection
por: Wang, Zijie, et al.
Publicado: (2018)

The Double-Edged Sword of Immunosuppressive Therapy in Kidney Transplantation: A Rare Case Report of Pulmonary Mucormycosis Post-Transplant and Literature Review
por: Zhang, Hengcheng, et al.
Publicado: (2020)

Vascular calcification progression and its association with mineral and bone disorder in kidney transplant recipients
por: Sun, Li, et al.
Publicado: (2023)

An intronic polymorphism of NFATC1 gene shows a risk association with biopsy-proven acute rejection in renal transplant recipients
por: Wang, Zijie, et al.
Publicado: (2020)

Single Nucleotide Polymorphisms of IL-33 Gene Correlated with Renal Allograft Fibrosis in Kidney Transplant Recipients
por: Liu, Xuzhong, et al.
Publicado: (2021)

Single-nucleotide polymorphisms of matrix metalloproteinase genes are associated with graft fibrosis after kidney transplantation
por: Zhang, Hengcheng, et al.
Publicado: (2023)

Evaluation of the NMP22 BladderChek test for detecting bladder cancer: a systematic review and meta-analysis
por: Wang, Zijie, et al.
Publicado: (2017)

Combined Immunotherapy With Belatacept and BTLA Overexpression Attenuates Acute Rejection Following Kidney Transplantation
por: Zhang, Hengcheng, et al.
Publicado: (2021)

The synergism of B and T lymphocyte attenuator (BTLA) and cytotoxic T lymphocyte associated antigen-4 (CTLA-4) attenuated acute T-cell mediated rejection and prolonged renal graft survival
por: Zhang, Hengcheng, et al.
Publicado: (2020)

Impact of complement component 3/4/5 single nucleotide polymorphisms on renal transplant recipients with antibody-mediated rejection
por: Wang, Zijie, et al.
Publicado: (2017)

BTLA suppress acute rejection via regulating TCR downstream signals and cytokines production in kidney transplantation and prolonged allografts survival
por: Zhang, Jiayi, et al.
Publicado: (2019)

Author Correction: BTLA suppress acute rejection via regulating TCR downstream signals and cytokines production in kidney transplantation and prolonged allografts survival
por: Zhang, Jiayi, et al.
Publicado: (2022)

Associations between HVEM/LIGHT/BTLA/CD160 polymorphisms and the occurrence of antibody-mediate rejection in renal transplant recipients
por: Wang, Zijie, et al.
Publicado: (2017)

Preparation of a Major Metabolite of Iguratimod and Simultaneous Assay of Iguratimod and Its Metabolite by HPLC in Rat Plasma
por: Han, Jun-ping, et al.
Publicado: (2019)

Impaired ATG16L-Dependent Autophagy Promotes Renal Interstitial Fibrosis in Chronic Renal Graft Dysfunction Through Inducing EndMT by NF-κB Signal Pathway
por: Gui, Zeping, et al.
Publicado: (2021)

Proton Nuclear Magnetic Resonance (1H-NMR)-Based Metabolomic Evaluation of Human Renal Allografts from Donations After Circulatory Death
por: Wang, Zijie, et al.
Publicado: (2017)

Iguratimod efficacy in palindromic rheumatism treatment
por: Yuan, Fangfang, et al.
Publicado: (2023)

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
por: Locke, Jayme E, et al.
Publicado: (2011)

Everolimus Alleviates Renal Allograft Interstitial Fibrosis by Inhibiting Epithelial-to-Mesenchymal Transition Not Only via Inducing Autophagy but Also via Stabilizing IκB-α
por: Gui, Zeping, et al.
Publicado: (2022)

Association Between a TLR2 Gene Polymorphism (rs3804099) and Proteinuria in Kidney Transplantation Recipients
por: Fei, Shuang, et al.
Publicado: (2022)

Efficacy and Safety of Iguratimod for the Treatment of Rheumatoid Arthritis
por: Li, Jiangtao, et al.
Publicado: (2013)

Belatacept-based immunosuppressive regimen in HIV-positive kidney transplant recipients
por: El Sakhawi, Karim, et al.
Publicado: (2020)

Immunosuppressive regimens on conversion of cytomegalovirus infection to disease in liver transplant recipients
por: Rabbani, Amirhassan, et al.
Publicado: (2022)

Clinical Efficacy and Safety of Pamidronate Therapy on Bone Mass Density in Early Post-Renal Transplant Period: A Meta-Analysis of Randomized Controlled Trials
por: Wang, Zijie, et al.
Publicado: (2014)

Association between Angiotensin I-Converting Enzyme Insertion/Deletion Polymorphism and Prognosis of Kidney Transplantation: A Meta-Analysis
por: Huang, Zhengkai, et al.
Publicado: (2015)

A Single-Nucleotide Polymorphism (rs1131243) of the Transforming Growth Factor Beta Signaling Pathway Contributes to Risk of Acute Rejection in Chinese Renal Transplant Recipients
por: Zheng, Ming, et al.
Publicado: (2019)

Iguratimod Inhibits the Aggressiveness of Rheumatoid Fibroblast-Like Synoviocytes
por: Lin, Jin, et al.
Publicado: (2019)

Iguratimod alleviates tubulo-interstitial injury in mice with lupus
por: Xue, Leixi, et al.
Publicado: (2022)

Construction of predictive model of interstitial fibrosis and tubular atrophy after kidney transplantation with machine learning algorithms
por: Yin, Yu, et al.
Publicado: (2023)

Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen
por: Zaza, Gianluigi, et al.
Publicado: (2017)

Elevated Incidence of Fractures in Solid-Organ Transplant Recipients on Glucocorticoid-Sparing Immunosuppressive Regimens
por: Edwards, B. J., et al.
Publicado: (2011)

Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens
por: Kirby, Sean, et al.
Publicado: (2012)

Tailored long-term immunosuppressive regimen for adult liver transplant recipients with hepatocellular carcinoma
por: Kang, Sung-Hwa, et al.
Publicado: (2014)

Cost utility analysis of immunosuppressive regimens in adult renal transplant recipients in England and Wales
por: Muduma, Gorden, et al.
Publicado: (2014)

Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape
por: Xie, Sisi, et al.
Publicado: (2020)

Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression
por: Liu, Yuan-Yuan, et al.
Publicado: (2015)

Association between fibrosis-related gene polymorphism and long-term allograft outcome in renal transplant recipients
por: Yin, Yu, et al.
Publicado: (2023)

Retraction: Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression
Publicado: (2019)

Corrigendum: Iguratimod as a New Drug for Rheumatoid Arthritis: Current Landscape
por: Xie, Sisi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_44df9e05jhh253vq2te5k2alm6